2Suppliers
2Customers
2Debt Items
12Related Chains

Mustang Bio, Inc. Suppliers

TickerNameConfidenceEvidence
FBIOP FBIOP 72% Item 1. Business ​ OVERVIEW Mustang Bio, Inc. (“Mustang,” “we,” “us,” “our” or the “Company”) is a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs into p…
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Item 1. Business ​ OVERVIEW Mustang Bio, Inc. (“Mustang,” “we,” “us,” “our” or the “Company”) is a clinical-stage bi…

Mustang Bio, Inc. Customers

TickerNameConfidenceEvidence
FBIOP FBIOP 72% n, future events or otherwise . ​ Table of Contents SUMMARY OF RISK FACTORS ​ Our business is subject to risks of which you should be aware before making an investment decision. The risks described b…
FBIOP FBIOP 72% Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Reciprocal relationship from FBIOP graph: Reciprocal relationship from MBIO graph: Reciprocal relationship from FBIO…

Mustang Bio, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
MBIO-DEBT-10879 Xbrl Convertible 90% xbrl convertible detail from xbrl 2023-12-31.
MBIO-DEBT-10878 Warrants outstanding: 288184 90% xbrl warrant detail from xbrl 2026-03-31.

Mustang Bio, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Mustang Bio, Inc..

Mustang Bio, Inc. Ownership

HolderNameConfidenceEvidence
MBIO-OWNER-KESTRA-ADVISORY-SERVICES-LLC Kestra Advisory Services, LLC 90% 13F overlay lists Kestra Advisory Services, LLC as top holder; 22 tracked holders.

Mustang Bio, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TGTX TG Therapeutics, Inc. 100.00 2
OCSL Oaktree Specialty Lending Corporation 100.00 2
DERM Journey Medical Corporation 100.00 2
FBIOP Fortress Biotech, Inc. 100.00 1 ['customer', 'supplier']
RDY Dr. Reddy's Laboratories Limited 50.00 2
AZN AstraZeneca PLC 50.00 2
ERNA Ernexa Therapeutics Inc. 50.00 2
FBIO Fortress Biotech, Inc. 38.88 1 ['receiving']
XYF X Financial 14.78 2
ATXI Avenue Therapeutics, Inc. 14.78 2
LLY Eli Lilly and Company 14.78 2
AXSM Axsome Therapeutics, Inc. 14.78 2